Shanghai Haohai Biological Technology Co. Ltd (5HB) — Cash Flow Quality Index
Shanghai Haohai Biological Technology Co. Ltd (5HB) has a Cash Flow Quality Index of 1.38x as of June 2023. Operating cash flow of €141.99 Million exceeds net income of €102.62 Million, indicating high earnings quality where cash backs reported profits. Explore Shanghai Haohai Biological Technology Co (5HB) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanghai Haohai Biological Technology Co. Ltd Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for Shanghai Haohai Biological Technology Co. Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Shanghai Haohai Biological Technology Co cash flow conversion.
Annual Cash Flow Quality Index for Shanghai Haohai Biological Technology Co. Ltd (2016–2025)
Year-by-year earnings quality comparison for Shanghai Haohai Biological Technology Co. Ltd.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.96x | €490.97 Million | €251.01 Million | ▲ +26.8% |
| 2024 | 1.54x | €648.57 Million | €420.45 Million | ▲ +1.2% |
| 2023 | 1.52x | €634.45 Million | €416.12 Million | ▲ +19.0% |
| 2022 | 1.28x | €231.30 Million | €180.47 Million | ▲ +32.0% |
| 2021 | 0.97x | €342.29 Million | €352.45 Million | ▼ -14.7% |
| 2020 | 1.14x | €262.07 Million | €230.07 Million | ▲ +21.0% |
| 2019 | 0.94x | €348.91 Million | €370.78 Million | ▼ -0.3% |
| 2018 | 0.94x | €391.28 Million | €414.54 Million | ▲ +2.5% |
| 2017 | 0.92x | €343.06 Million | €372.42 Million | ▲ +10.4% |
| 2016 | 0.83x | €254.49 Million | €305.05 Million | — |